Helping Hospital Infection Control: reOpenTest's Reliable C. difficile Testing Solutions
Clostridium difficile (C. difficile) is one of the main pathogens causing healthcare-associated infections (HAI), posing a serious challenge to patient safety and healthcare costs. Learn how our high-quality GDH and Toxin A/B rapid detection reagents can help your hospital clients effectively conduct C. diff screening and diagnosis, implement precise infection control measures, and curb nosocomial transmission.
Get a Quote for C. diff Testing ProductsC. difficile: A Serious Challenge for Hospital Infection Control
The main cause of nosocomial infections
C. difficile infection (CDI) is the most common cause of antibiotic-associated diarrhea and pseudomembranous colitis, significantly increasing patients' length of stay, risk of complications, and medical expenses.
Easy to spread, difficult to control
C. difficile produces spores that are highly resistant to the environment and can spread rapidly within healthcare facilities through contact with patients or contaminated environmental surfaces, posing a significant challenge to infection control.
Rapid diagnosis is crucial
Timely and accurate identification of CDI patients is key to implementing effective isolation measures, guiding rational drug use, and cutting off transmission routes, which is crucial for improving patient prognosis and controlling outbreaks.
reOpenTest C. difficile Testing Solution: Reliable and Efficient
Glutamate Dehydrogenase (GDH) Antigen Detection
GDH is a common enzyme produced by C. difficile. Our GDH antigen rapid test has high sensitivity and is an ideal screening tool for quickly ruling out negative samples, effectively reducing subsequent unnecessary toxin testing and optimizing the testing process.
Learn moreToxin A/B Antigen Detection
Directly detect the key pathogenic factors that cause clinical symptoms of CDI - Toxin A and/or Toxin B. This test has high specificity and is an important basis for confirming active CDI infection and guiding clinical treatment.
Learn moreGDH / Toxin A/B Combination Test
Integrates high-sensitivity GDH screening with high-specificity toxin confirmation on a single test strip. A single step provides both screening and confirmation results, greatly simplifying the operation process and improving laboratory diagnostic efficiency.
Learn morereOpenTest C. difficile series of detection reagents are easy to operate, providing reliable results within 15 minutes, and have passed strict quality control and clinical validation.
Clinically Validated Reliable Performance
Our C. difficile detection reagents have undergone extensive clinical evaluation and demonstrate excellent performance compared to gold standard methods (such as Cytotoxin Neutralization Assay CTNA, Toxin Gene PCR). The following is a summary of some performance data:
| Test Item | Sensitivity (%) | Specificity (%) | Comparison Method |
|---|---|---|---|
| GDH Antigen Detection | ≥95% | ≥98% | Toxin Gene PCR / Anaerobic Culture |
| Toxin A/B Antigen Detection | ≥92% | ≥99% | Cytotoxin Neutralization Assay (CTNA) / Toxin Gene PCR |
*Specific performance data may vary slightly depending on the sample type and comparison method. Please refer to the corresponding product instructions or contact us for a complete clinical evaluation report for detailed information.
Empowering Distributors: How to promote reOpenTest C. diff testing to your hospital clients?
- Emphasize the value of infection control:Highlight the critical role of rapid and accurate C. diff testing in early identification, patient isolation, treatment guidance, and prevention of nosocomial outbreaks.
- Promote the two-step strategy:Explain the clinical significance and cost-effectiveness of combining GDH as an efficient screening tool (high negative predictive value) with Toxin A/B as a confirmatory tool (high positive predictive value).
- Provide reliable evidence:Showcase the product's excellent sensitivity and specificity data, as well as qualifications such as CE certification, to enhance the confidence of clinical laboratories and infection control physicians in product quality.
- Combine guidelines and practice:Cite relevant national or regional CDI diagnostic guidelines and best practices for hospital infection control to illustrate how reOpenTest products meet or exceed these requirements.
- Provide a holistic solution:In addition to providing detection reagents, we can also provide relevant operational training and technical support to become a reliable partner for hospital infection control.
Help hospital clients win the infection control market
Choose reOpenTest's high-quality, high-performance C. difficile detection reagents to provide your hospital clients with a powerful weapon against nosocomial infections. We are committed to providing comprehensive support to our distributor partners. Contact us now for product details and cooperation policies.